Andrew Fielding - Research Portal | Lancaster University

Keywords

Cancer biology

Current Postgraduate Research Students

Andrew Fielding supervises 2 postgraduate research students. If these students have produced research profiles, these are listed below:

View graph of relations

Dr Andrew Fielding

North West Cancer Research (NWCR) Lecturer

Biomedical and Life Sciences

Furness Building

LA1 4YG

Lancaster

E-mail: Show email

Tel: +44 1524 593262

ORCID: 0000-0002-3170-9966

Research overview

Cancer is a disease characterised by errors in cell cycle regulation, leading to uncontrolled cell proliferation. However, these errors also lead to cancer cells possessing unique phenotypes, such as centrosome amplification, which could potentially decrease their survival. In my laboratory we aim to understand these phenotypes and in turn target these to provide cancer-specific methods for inhibiting cell proliferation.

PhD supervision

I am always very happy to discuss MSc by Research and PhD projects, in the field of cancer cell biology. Can currently offer projects in several areas including: 1. Understanding and targeting centrosome amplification in cancer. 2. The interplay between DNA damage, the cell cycle and centrosome amplification.

Show more...Show less

Publications & Outputs

Published
Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention
Sabat‐Pośpiech, D., Fabian‐Kolpanowicz, K., Kalirai, H., Kipling, N., Coupland, S. E., Coulson, J. M. & Fielding, A. B., 31/07/2022, In: The Journal of Pathology: Clinical Research. 8, 4, p. 383-394 12 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Targeting centrosome amplification, an Achilles' heel of cancer
Sabat-Pośpiech, D., Fabian-Kolpanowicz, K., Prior, I. A., Coulson, J. M. & Fielding, A. B., 31/10/2019, In: Biochemical Society Transactions. 47, 5, p. 1209-1222 14 p.
Research output: Contribution to Journal/Magazine › Review article › peer-review
Published
Altered Nuclear Expression of the Deubiquitylase BAP1 Cannot be Used as a Prognostic Marker for Canine Melanoma
Jama, N., Farquhar, N., Butt, Z., Coupland, S. E., Sacco, J. J., Scase, T., Fielding, A. B., Coulson, J. M., Kalirai, H. & Killick, D. R., 07/2018, In: Journal of Comparative Pathology. 162, p. 50-58 9 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review

View all (25) »

Activities

Lancaster mini melanocyte Symposium 2022
Activity: Participating in or organising an event types › Participation in conference
External examiner for PhD viva
Activity: Examination types › Examination
MSc by Research: Internal examiner
Activity: Examination types › Examination

View all (31) »

Research

Keywords

Current Postgraduate Research Students

Dr Andrew Fielding

Research overview

PhD supervision

Publications & Outputs

Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention

Targeting centrosome amplification, an Achilles' heel of cancer

Altered Nuclear Expression of the Deubiquitylase BAP1 Cannot be Used as a Prognostic Marker for Canine Melanoma

Activities

Lancaster mini melanocyte Symposium 2022

External examiner for PhD viva

MSc by Research: Internal examiner

Quick Links

Connect With Us

Faculties & Depts

Contact Us